HUMA
USDHumacyte Inc. Common Stock
Preço em tempo real
Gráfico de preços
Métricas-chave
Métricas de mercado
Abertura
$1.300
Máximo
$1.340
Mínimo
$1.220
Volume
3.25M
Fundamentos da empresa
Capitalização de mercado
249.1M
Setor
Biotecnologia
País
United States
Estatísticas de negociação
Volume médio
5.40M
Bolsa de valores
NMS
Moeda
USD
Faixa de 52 semanas
Notícias relacionadas
BTIG Maintains Buy on Humacyte, Lowers Price Target to $6
BTIG analyst Ryan Zimmerman maintains Humacyte with a Buy and lowers the price target from $7 to $6.
Humacyte Announces Pricing of $60.0 Million Oversubscribed Registered Direct Offering
DURHAM, N.C., Oct. 07, 2025 (GLOBE NEWSWIRE) -- Humacyte, Inc. (NASDAQ:HUMA), a commercial-stage biotechnology platform company developing universally implantable, bioengineered human tissues at commercial scale, today
D. Boral Capital Maintains Buy on Humacyte, Maintains $25 Price Target
D. Boral Capital analyst Jason Kolbert maintains Humacyte with a Buy and maintains $25 price target.
Humacyte Announces Expansion of Intellectual Property for Pipeline Products with Granting of New U.S. Patent for Bioengineered Esophagus
– Patent covers esophagus produced using Humacyte's proprietary bioengineered regenerative tissue platform, designed for implant in patients with damaged esophagus –
Ações relacionadas
WMPN
William Penn Bancorporation
DDT
Dillard's Capital Trust I
HTFB
Horizon Technology Finance Corporation 4.875% Notes due 2026
ATHE
Alterity Therapeutics Limited American Depositary Shares
MACIW
Melar Acquisition Corp. I Warrant
Mantenha-se atualizado
Defina um alerta de preço, obtenha atualizações de análise de IA e notícias de mercado em tempo real.